Epic and Tempus represent two fundamentally different philosophies for bringing AI into healthcare. Epic embeds AI into the existing EHR workflow — ambient documentation, inbox triage, order suggestions — keeping the physician inside a familiar interface. Tempus builds a parallel data infrastructure, ingesting clinical and genomic data to power precision medicine insights that flow back to clinicians through dashboards and reports.
As someone building AI products across clinical trials, MedTech, and BioPharma at HCLTech, I've studied both approaches extensively. This comparison isn't about which company is "better" — it's about understanding two architectural philosophies that shape how healthcare AI gets adopted.
Philosophy: Workflow-First vs. Data-First
Epic's approach: AI should be invisible. It lives inside the EHR where physicians already work. Epic's ambient listening (powered by Nuance/DAX integration), Hey Epic! natural language queries, and predictive deterioration alerts all operate within the Epic Hyperspace UI. The physician doesn't open a new app or visit a dashboard — the AI comes to them.
Tempus's approach: AI needs better data first. Tempus spent its first five years building a structured multimodal dataset — clinical records, genomic sequences, imaging, pathology slides — across 7,000+ oncologists and 100M+ clinical records. The AI insights emerge from this curated dataset, not from whatever happens to be in the EHR.
This is the classic build-on-existing-infrastructure vs. build-new-infrastructure debate, and it has profound implications for product strategy.
Data Architecture
Epic: Works with whatever data is in the customer's EHR instance. This means data quality varies wildly across health systems. Epic's AI models must be robust to missing fields, inconsistent coding practices, and different documentation styles. The advantage: zero data migration. The disadvantage: garbage in, garbage out.
Tempus: Actively curates and structures data before feeding it to models. They employ teams of clinical data abstractors who standardize records into a consistent schema. They also generate new data through their molecular sequencing lab (Tempus xT, xF, xR panels). The advantage: clean, structured, multimodal data. The disadvantage: massive upfront cost and limited to participating institutions.
AI Model Strategy
Epic: Partners with foundational model providers (Microsoft/OpenAI for ambient, in-house for clinical predictions). Epic's moat isn't the model — it's the distribution. With 305M+ patient records across 250+ health systems, any model deployed through Epic instantly has massive reach. Epic is a platform, not an AI lab.
Tempus: Builds proprietary models trained on their curated dataset. Their algorithmic tests (like Tempus ECG-AF for atrial fibrillation risk from normal ECGs) are FDA-cleared medical devices. Tempus is part data company, part diagnostics company, part AI lab. Their moat is the dataset, not distribution.
Market Positioning
Epic targets health system CIOs and CMIOs — the people who already pay for Epic licenses. AI features are bundled or sold as add-ons to existing contracts. Switching costs are astronomical (Epic implementations cost $500M+ for large systems). This is a lock-in strategy enhanced by AI.
Tempus targets oncologists, pathologists, and biopharma companies. Revenue comes from molecular testing (reimbursed by payers), data licensing to pharma, and clinical trial matching. This is a marketplace strategy — connecting data generators (health systems) with data consumers (pharma).
Implications for Product Managers
If you're building healthcare AI products, the Epic vs. Tempus comparison teaches three lessons:
- Distribution beats model quality. Epic's AI isn't more sophisticated than Tempus's, but it reaches 10x more physicians because it's embedded in the workflow they already use.
- Data quality requires investment. Tempus proves that structured, curated data produces meaningfully better clinical insights than raw EHR data. But the cost of data curation is substantial.
- Pick your buyer. Epic sells to health system IT. Tempus sells to clinicians and pharma. Your go-to-market strategy should determine your product architecture, not the other way around.
The future likely involves both approaches converging: Epic adding more data curation capabilities, and Tempus building deeper EHR integrations. The question for product managers is which starting point gives you faster time-to-value for your specific use case.
Frequently Asked Questions
What is Epic's AI strategy in healthcare?
Epic embeds AI directly into its EHR workflow through ambient documentation (DAX/Nuance integration), Hey Epic! natural language queries, and predictive clinical alerts. Epic's strategy is distribution-first — any AI model deployed through Epic reaches 305M+ patient records across 250+ health systems. Epic partners with foundational model providers like Microsoft/OpenAI rather than building its own models.
How does Tempus use AI differently from Epic?
Tempus takes a data-first approach, building a curated multimodal dataset of clinical records, genomic sequences, imaging, and pathology slides across 100M+ clinical records. Tempus builds proprietary AI models trained on this curated data, including FDA-cleared algorithmic tests like ECG-AF for atrial fibrillation risk detection. Unlike Epic, Tempus generates its own data through molecular sequencing labs.
Which is better for healthcare AI startups — Epic or Tempus's approach?
It depends on your go-to-market strategy. If you're selling to health system IT leaders and need broad distribution, Epic's platform approach (embedding AI into existing EHR workflows) is the model to follow. If you're selling to clinicians or pharma companies and your differentiation is data quality, Tempus's approach (curated datasets powering proprietary models) is more relevant. Distribution beats model quality for adoption; data quality beats distribution for clinical accuracy.
